Marc Van de Vijver
Overview
Explore the profile of Marc Van de Vijver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
6158
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen H, Geukens T, Maetens M, Aparicio S, Bassez A, Borg A, et al.
Nat Commun
. 2023 Jul;
14(1):4418.
PMID: 37479706
Obesity is associated with an increased risk of developing breast cancer (BC) and worse prognosis in BC patients, yet its impact on BC biology remains understudied in humans. This study...
2.
Bosma S, Leij F, Vreeswijk S, de Maaker M, Wesseling J, Van de Vijver M, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jan;
106(5):958-967.
PMID: 31987957
Purpose: In this multicenter phase 2 feasibility study, we investigated the impact of preoperative accelerated partial breast irradiation (PAPBI) on local control, breast fibrosis, and cosmetic outcome. Methods And Materials:...
3.
Kumar R, Van de Vijver M, Tortora G, Ciardiello F, Goldkorn T, Miller Jr W, et al.
Cancer Res
. 2019 Jun;
79(17):4315-4323.
PMID: 31213466
Cancer scientists and clinicians are mourning the death of one of the most accomplished members of their community: Dr. John Mendelsohn. He was a pioneer in targeted cancer therapy and...
4.
Soer E, Brosens L, Van de Vijver M, Dijk F, van Velthuysen M, Farina-Sarasqueta A, et al.
Virchows Arch
. 2018 Mar;
472(4):533-543.
PMID: 29589102
A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached by the pathologist. In this review, we provide an overview of topics relevant for...
5.
Ju Y, Martincorena I, Gerstung M, Petljak M, Alexandrov L, Rahbari R, et al.
Nature
. 2017 Mar;
543(7647):714-718.
PMID: 28329761
Somatic cells acquire mutations throughout the course of an individual's life. Mutations occurring early in embryogenesis are often present in a substantial proportion of, but not all, cells in postnatal...
6.
Torres-Roca J, Fulp W, Caudell J, Servant N, Bollet M, Van de Vijver M, et al.
Int J Radiat Oncol Biol Phys
. 2015 Oct;
93(3):631-8.
PMID: 26461005
Purpose: Recently, we developed radiosensitivity (RSI), a clinically validated molecular signature that estimates tumor radiosensitivity. In the present study, we tested whether integrating RSI with the molecular subtype refines the...
7.
Tubio J, Li Y, Ju Y, Martincorena I, Cooke S, Tojo M, et al.
Science
. 2014 Aug;
345(6196):1251343.
PMID: 25082706
Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences...
8.
Hanna W, Ruschoff J, Bilous M, Coudry R, Dowsett M, Osamura R, et al.
Mod Pathol
. 2013 Jun;
27(1):4-18.
PMID: 23807776
Trastuzumab-containing therapy is a standard of care for patients with HER2+ breast cancer. HER2 status is routinely assigned using in situ hybridization to assess HER2 gene amplification, but interpretation of...
9.
Stephens P, Tarpey P, Davies H, Van Loo P, Greenman C, Wedge D, et al.
Nature
. 2012 Jun;
486(7403):400-4.
PMID: 22722201
All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncogenesis, and the remainder...
10.
Ruschoff J, Hanna W, Bilous M, Hofmann M, Osamura R, Penault-Llorca F, et al.
Mod Pathol
. 2012 Jan;
25(5):637-50.
PMID: 22222640
Trastuzumab in combination with capecitabine or 5-fluorouracil and cisplatin is approved by the European Medicines Agency for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive (immunohistochemistry...